DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20150536

Neuromyelitis optica: a demyelinating disease

Ayesha Imran, Nitin Avinash Yelikar, Sneha Borse, Shreyash Shah

Abstract


Neuromyelitis optica (NMO) also known as Devic’s disease is a demyelinating disease. It involves the central nervous system and predominantly affects the spinal cord and optic nerves. It is characterised by episodes of optic neuritis and/or transverse myelitis. It is often confused with multiple sclerosis. NMO can occur rarely in children but cases of pediatric NMO need specific consideration owing to possible poor visual and motor outcome. We report a case of nine year male child admitted with history of fever followed by sudden weakness of body, sudden decline in visual acuity and involuntary passage of urine. The symptoms were reverted after the use of methylprednisolone. Clinical outcome was favourable with disappearance of sphincter troubles, improvement of visual acuity and progressive disappearance of motor troubles.


Keywords


Neuromyelitis optica, Optic neuritis, Multiple sclerosis, Methylprednisolone

Full Text:

PDF

References


Jarius S, Wildemann B. The history of neuromyelitis optica. J Neuroinflamm. 2013;10:8.

Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964-8.

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485-9.

Wingerchuk, DM. Neuromyelitis optica. Int MS J. 2006;13(2):42-50.

Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-12.

Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, Tavazzi E, Piccolo G, et al. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: Differences in repeated cerebrospinal fluid examinations. Mult Scler. 2004;10:2-4.

Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805-15.

Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol. 2008;10:55-66.

Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. Eur J Neurol. 2007;14(6):e12-3.